BANBN Stock Chart & Stats
$1700.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1700.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1,510.54 - $1,745.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$120.11B
Enterprise Value$5.83K
Total Cash (Recent Filing)$51.57M
Total Debt (Recent Filing)$208.10M
Price to Earnings (P/E)37.6
Beta0.17
Next Earnings
Mar 04, 2027EPS Estimate
33.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.99
Shares Outstanding75,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.27
Price to Book (P/B)3.08
Price to Sales (P/S)6.46
P/FCF Ratio-93.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,655.81Price Target Upside-2.60% Downside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)50.58
Revenue Forecast (FY)$20.23B
Bulls Say, Bears Say
Bulls Say
Conservatively Financed Balance SheetExtremely low leverage and a growing equity base provide durable financial resilience. Low debt reduces interest burden, preserves borrowing capacity for capex or acquisitions, and supports continuity of regulated manufacturing operations through industry cycles and funding shocks.
Specialized CDMO Model With Steady Revenue GrowthBachem's integrated CDMO offering (development, scale-up, commercial supply) creates long lifecycle customer relationships and recurring revenue as programs transition to commercial supply. Steady multi-year revenue growth underpins durable demand and scale advantages in a niche, high-barrier market.
Solid Profitability And Operating Cash GenerationHealthy net margins (~21%) and improved operating cash flow indicate operational efficiency and pricing power in specialized APIs. Sustained operating profitability supports reinvestment in capacity, R&D, and quality systems essential for regulated CDMO services over the medium term.
Bears Say
Persistent Negative Free Cash Flow And Uneven Cash ConversionSustained negative free cash flow despite positive operating cash highlights that capex or working-capital needs are absorbing cash. Over months, this reduces internal funding for growth, increases reliance on external financing, and raises execution risk for capacity expansion.
Gradual Margin Compression Versus Prior PeriodsA trend of margin drift versus 2021–2022 suggests emerging cost pressures or mix shifts toward lower-margin projects. If persistent, this structural erosion can weaken return on new contracts and limit the company's ability to self-fund investments and maintain dividend or reinvestment policies.
Step-up In Debt In 2025 Raises Flexibility RiskThe increase in total debt in 2025, while modest versus equity, raises fixed obligations at a time of uneven cash conversion. Rising leverage combined with negative FCF elevates refinancing and flexibility risks if investment or working-capital demands continue over the medium term.
Bachem Holding AG News
BANBN FAQ
What was Bachem Holding AG Class B’s price range in the past 12 months?
Bachem Holding AG Class B lowest stock price was $1510.54 and its highest was $1745.00 in the past 12 months.
What is Bachem Holding AG Class B’s market cap?
Bachem Holding AG Class B’s market cap is $120.11B.
When is Bachem Holding AG Class B’s upcoming earnings report date?
Bachem Holding AG Class B’s upcoming earnings report date is Mar 04, 2027 which is in 211 days.
How were Bachem Holding AG Class B’s earnings last quarter?
Bachem Holding AG Class B released its earnings results on Jul 30, 2026. The company reported $14.299 earnings per share for the quarter, beating the consensus estimate of $9.988 by $4.311.
Is Bachem Holding AG Class B overvalued?
According to Wall Street analysts Bachem Holding AG Class B’s price is currently Overvalued.
Does Bachem Holding AG Class B pay dividends?
Bachem Holding AG Class B does not currently pay dividends.
What is Bachem Holding AG Class B’s EPS estimate?
Bachem Holding AG Class B’s EPS estimate is 33.61.
How many shares outstanding does Bachem Holding AG Class B have?
Bachem Holding AG Class B has 75,000,000 shares outstanding.
What happened to Bachem Holding AG Class B’s price movement after its last earnings report?
Bachem Holding AG Class B reported an EPS of $14.299 in its last earnings report, beating expectations of $9.988. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bachem Holding AG Class B?
Currently, no hedge funds are holding shares in MX:BANBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bachem Holding AG Class B
Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
BANBN Stock 12 Month Forecast
Average Price Target
$1,655.81
▼(-2.60% Downside)